Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Preferred Stock
Convertible Preferred Stock
Preferred Stock
Series B preferred stock
Common Shares
Series B preferred stock
Common Shares
Convertible Promissory Note
Common Shares
Additional Paid-in Capital
ASC842 adoption adjustment
Additional Paid-in Capital
Series B preferred stock
Additional Paid-in Capital
Convertible Promissory Note
Additional Paid-in Capital
Accumulated Deficit
Series B preferred stock
Convertible Promissory Note
Total
Balance at Dec. 31, 2022 $ 0       $ 1,000       $ 226,324,000 $ (228,321,000)     $ (1,996,000)
Balance (in shares) at Dec. 31, 2022 0       4,750                
Stock-based compensation                 2,058,000       $ 2,058,000
Stock-based compensation (in shares)         6,427                
Restricted stock awards cancelled (in shares)         (88)                
Release of vested restricted common stock (in shares)         19                
Issuance of common stock in connection with convertible securities             $ 6,341,000 $ 708,000     $ 6,341,000 $ 708,000  
Issuance of common stock in connection with convertible securities (In shares)       450                 187,557
Issuance of common stock in connection with warrant exercise                 10,713,000       $ 10,713,000
Issuance of common stock in connection with warrant exercise (in shares)         19,030                
Issuance of common stock and warrants, net of offering costs                 2,319,000       2,319,000
Issuance of common stock and warrants, net of offering costs (in shares)         14,510,000                
Issuance of Series B preferred stock, net of discounts             1,909,000       1,909,000    
Issuance of Series B preferred stock, net of discount (in shares) 87,000                        
Repurchase of common stock warrants                 (2,323)       (2,323)
Deemed dividend in connection with amortization and accretion of discounts relating to Series B preferred stock   $ 297         (297)       (297)    
Discount from issuance of common stock warrants in connection with Series B preferred stock inducement   (3,322)                      
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts   $ 3,550,000         195,000       195,000    
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts (in shares)   61,613                      
Issuance of common stock in connection with conversion of Series B preferred stock   $ (6,341,000)                      
Issuance of common stock in connection with conversion of Series B preferred stock (in shares) (110,278)   177,282                    
Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock   6,063         (6,063)       (6,063)    
Net Income (Loss)                   (18,721)     (18,721,000)
Balance at Dec. 31, 2023 $ 247,000       $ 1,000       241,884,000 (247,042,000)     (5,157,000)
Balance (in shares) at Dec. 31, 2023 38,335       222,380                
Stock-based compensation                 2,536,000       2,536,000
Stock-based compensation (in shares)         1,233,683                
Issuance of common stock in connection with warrant amendment (in shares)         887,356                
Restricted stock awards cancelled (in shares)         (3,941)                
Issuance of common stock in connection with convertible securities             325,000       325,000    
Issuance of common stock in connection with warrant exercise                 7,794,000       7,794,000
Issuance of common stock in connection with warrant exercise (in shares)         5,456,986                
Issuance of common stock and warrants, net of offering costs                 8,756,000       8,756,000
Issuance of common stock and warrants, net of offering costs (in shares)         2,466,583                
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts   386,000                      
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts (in shares) 29,322                        
Issuance of common stock in connection with conversion of Series B preferred stock   (325,000)                      
Issuance of common stock in connection with conversion of Series B preferred stock (in shares) (5,000)   8,038                    
Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock   5,842         (5,842)       (5,842)    
Repurchase of Series B preferred stock and Series B preferred stock warrants   $ (6,266,000)         $ 824,000       $ 824,000    
Repurchase of Series B preferred stock and Series B preferred stock warrants (in shares) (62,657)                        
Issuance of common stock, pre-funded units and warrants, net of offering costs                 4,210,000       4,210,000
Issuance of common stock, pre-funded units and warrants, net of offering costs (in shares)         1,442,518                
Issuance of common stock in connection with reverse split rounding-up for fractional shares (in shares)         84,254                
Issuance of common stock to vendors                 600,000       600,000
Issuance of common stock to vendors (in shares)         236,203                
Issuance of common stock in connection with the acquistion         $ 4,000       81,995,000       $ 81,999,000
Issuance of common stock in connection with the acquistion (shares)         40,000,000               40,000,000
Conversion of liability warrants to equity warrants                 41,851       $ 41,851
Warrants classified to liability                 (645)       (645)
Net Income (Loss)                   (51,409)     (51,409,000)
Balance (Accounting Standards Update 2020-06) at Dec. 31, 2024 $ 116         $ 116,000     (116)       (116)
Balance at Dec. 31, 2024         $ 5,000       $ 384,172,000 $ (298,451,000)     $ 85,726,000
Balance (in shares) at Dec. 31, 2024         52,034,060